Discontinuation report LOSARTAN
| Report ID | 198179 |
| Drug Identification Number | 02394383 |
| Brand name | LOSARTAN |
| Common or Proper name | LOSARTAN |
| Company Name | PRO DOC LIMITEE |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | LOSARTAN POTASSIUM |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30-100 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-07-10 |
| Remaining supply date | 2023-07-10 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-07-11 | French | Compare |
| v1 | 2023-07-11 | English | Compare |
Showing 1 to 2 of 2